A CDC report shows improvement in quality of some vitamin D tests, while physicians still seek to both improve their ...

Though many patients are advised to stop SGLT2s at hospital admission, new results from the ENDORSE-HF trial suggest that ...

Patients with early rheumatoid arthritis who had higher tender-swollen joint differences showed deteriorating ...

An artificial intelligence-assisted capsule endoscopy reading may provide more accurate and faster detection of small bowel ...

Narcolepsy is associated with an increased risk for CVD, independent of common comorbid conditions and medications used to ...

Hypogammaglobulinemia is a known risk linked to B-cell–depleting therapies, but a real-world study has specified the risk and ...

The CEO of Masimo speaks with WebMD CMO John Whyte, MD, MPH, about how wearables and AI can advance home-based care.

Inebilizumab -cdon, a monoclonal antibody that depletes B cells, reduces the risk for flares without showing any new safety ...

Recently approved by the US Food and Drug Administration, catheter-directed thrombolysis improved heart function and clot ...

The experimental IL-6 inhibitor clazakizumab improves key inflammation markers in one study, whereas another shows lower ...

Several promising drugs in phase 2 testing and beyond seek to offer patients a more convenient alternative to already popular ...

The global prevalence of celiac disease is increasing, as is the need to develop novel interventions to replace the ...